Speculative Bullish Options Positioning in Bristol-Myers Squibb (BMY) -Susquehanna

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T
6. SPY
7. CVS
8. UNH
9. TMUS
10. LMT

Go back to Speculative Bullish Options Positioning in Bristol-Myers Squibb (BMY) -Susquehanna

Bristol-Myers Squibb (BMY) Announces Presentations at IASLC

September 27, 2017 5:07 PM EDT

Bristol-Myers Squibb Company (NYSE: BMY) today announced the presentation of 28 abstracts for Opdivo (nivolumab), alone and in combination with Yervoy (ipilimumab), targeted therapy or chemotherapy, at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) in Yokohama, Japan, from October 15-18. Data from company-sponsored studies, clinical collaborations and... More

Bristol-Myers Squibb (BMY) Investor Meeting Feedback Comments From Jefferies

September 27, 2017 7:54 AM EDT

Jefferies maintains Buy on Bristol-Myers Squibb Co. (NYSE: BMY) price target of $72.00.

Analyst Jeff Holford says business development remains a top priority at the company noting the firm remains agnostic on deal size and listed three criteria when evaluating... More